awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38861026-2BF6445E-F578-415B-9EC0-FD5945C5BE2D
Q38861026-2BF6445E-F578-415B-9EC0-FD5945C5BE2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38861026-2BF6445E-F578-415B-9EC0-FD5945C5BE2D
Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations.
P2860
Q38861026-2BF6445E-F578-415B-9EC0-FD5945C5BE2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38861026-2BF6445E-F578-415B-9EC0-FD5945C5BE2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
841c2ada9e9599370c36408b07424950e384ac8c
P2860
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...